Abstract
Piperazine derivatives are a class of psychoactive substances applied in prescription medicines like antidepressants as well as in drugs of abuse. They are known to increase brain levels of catecholamines, likely via reversal of reuptake transporters. However, other mechanisms could also contribute to increased neurotransmitter levels, e.g., reduced inhibitory inputs on catecholaminergic neurons. Inhibition of the main inhibitory input in the brain, the GABAergic system, by piperazine derivatives could contribute to increased neurotransmitter levels. Our previous studies support this by demonstrating that 1-(3-chlorophenyl)piperazine (3CPP/mCPP) is an antagonist of the human α1β2γ2 GABAA receptor (GABAA-R). We therefore investigated the effect of 12 additional piperazine derivatives on the function of the human α1β2γ2 GABAA-R expressed in Xenopus oocytes, using the two-electrode voltage-clamp technique. Tested derivatives included benzylpiperazine (BZP), methylbenzylpiperazines (2/3MBP), phenylpiperazine (PP), methoxyphenylpiperazines (2/3/4MPP/MeOPP), chlorophenylpiperazines (2/4CPP) and fluorophenylpiperazines (4FPP/TFMPP). All derivatives concentration-dependently inhibited the GABA-evoked ion current. Chlorophenylpiperazine...Continue Reading
References
Jan 24, 1986·Journal of Chromatography·R L Miller, C L DeVane
Nov 1, 1985·Neuropharmacology·T M Smith, R F Suckow
Sep 1, 1994·Psychiatry Research·S SevyH M van Praag
Apr 1, 1996·Trends in Neurosciences·R M McKernan, P J Whiting
Sep 15, 1996·Biological Psychiatry·D J SteinB Aronowitz
Jul 29, 1998·Neuroscience·E A Kiyatkin, G V Rebec
Aug 15, 1998·Psychiatry Research·T KlaassenH M van Praag
Dec 4, 1998·Biological Psychiatry·S RotzingerG B Baker
Dec 2, 2000·Nature Neuroscience·R J WaltersJ Amin
Apr 3, 2001·The International Journal of Neuropsychopharmacology·C. Lindsay DeVaneRonald L. Miller
Apr 23, 2004·European Journal of Pharmacology·Belinda J HallGraham A R Johnston
Aug 17, 2004·The Journal of Biological Chemistry·Donald D Brown
Jun 25, 2005·Journal of Analytical Toxicology·María A MartínezElena Almarza
Jan 16, 2007·European Journal of Pharmacology·Fumiko NagaiKanako Satoh Hisashi Kamimura
Feb 20, 2007·Resuscitation·Adeline Su-Yin NgoR Ponampalam
May 1, 2007·Lancet·David M WoodAlison L Jones
Jun 4, 2008·Therapeutic Drug Monitoring·Julia KovalevaAlain Verstraete
Jul 7, 2009·Drug Discovery Today·Charlotte D'HulstR Frank Kooy
Sep 8, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Elsa C Antunes FernandesRemco H S Westerink
Sep 24, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Hester S HendriksRemco H S Westerink
Apr 19, 2011·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Leo J SchepPaul Gee
Jul 7, 2011·Neurotoxicology·L HondebrinkR H S Westerink
Jul 30, 2011·Nature Reviews. Drug Discovery·Uwe Rudolph, Frédéric Knoflach
Nov 11, 2011·Drug and Alcohol Dependence·M D ArboH F Carmo
Jul 17, 2012·Australian Dental Journal·Jason Armfield
Dec 26, 2012·Neurotoxicology·Laura HondebrinkRemco H S Westerink
Citations
May 7, 2016·Neurotoxicology·L HondebrinkR H S Westerink
May 22, 2016·Drug and Alcohol Dependence·D P KatzM Dhanasekaran
Apr 5, 2019·The Journal of Biological Chemistry·Joseph T OrtegaBeata Jastrzebska
Mar 27, 2020·Scientific Reports·Anke M TukkerRemco H S Westerink
Feb 9, 2021·Heliyon·Neeraj ChoudharyAshish Suttee
Nov 4, 2017·Pharmacology & Therapeutics·Laura HondebrinkRemco H S Westerink